Efficacy of first-line tagraxofusp in blastic plasmacytoid dendritic cell neoplasm with prior or concomitant hematologic malignancy: subgroup analysis of a pivotal trial
Year: 2025
Type: article
Abstract: To the EditorBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive, orphan hematologic malignancy characterized by tumor cell clonal expansion with features of plasmacytoid dendriti...
Institutions: The University of Texas MD Anderson Cancer Center, Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, Moffitt Cancer Center, City Of Hope National Medical Center, City of Hope, Novant Health, Roswell Park Comprehensive Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Herbert Irving Comprehensive Cancer Center, Menarini Group (Luxembourg), Menarini Group (Italy), Menarini Group (Germany), Dana-Farber Cancer Institute
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funder: Menarini Group
OpenAlex ID: W4408305614